Annual General Meeting Details for Novo Nordisk Shareholders
Annual General Meeting Announcement
In a significant engagement for its shareholders, Novo Nordisk A/S is gearing up for its Annual General Meeting. This important event will take place on Thursday, March 27, at 14:00 CET, bringing together shareholders to discuss the company’s future.
Meeting Format and Participation
This year, the Annual General Meeting is designed to be partially electronic. Shareholders can either participate in person at the Bella Center in Copenhagen or join virtually through a dedicated IT application. The flexibility offered encourages everyone to exercise their voting rights by submitting proxies or votes via correspondence ahead of time.
Webcast Access
For those unable to attend in person, Novo Nordisk will offer a live webcast of the meeting on its official website. This ensures all shareholders can stay informed and participate remotely.
Board of Directors Elections
The Board of Directors will see all its members up for re-election during this Annual General Meeting. Key proposals include the re-election of Helge Lund as Chair and Henrik Poulsen as Vice Chair. Additional nominees include Laurence Debroux, Andreas Fibig, Sylvie Grégoire, Kasim Kutay, Christina Law, and Martin Mackay to continue as Board members.
Novo Nordisk's Commitment to Healthcare
Novo Nordisk has established itself as a leading player in global healthcare since its inception in 1923. The organization is particularly renowned for its dedication to combating serious chronic diseases, particularly through innovation in diabetes treatment. With a workforce of about 76,300 employees in 80 countries, and the marketing of products across approximately 170 nations, Novo Nordisk's reach is truly global.
Financial Market Presence
The company maintains a strong presence in the financial markets as well. Its B shares are identified on Nasdaq Copenhagen as Novo-B, while its American Depositary Receipts (ADRs) are traded on the New York Stock Exchange under the ticker NVO. This dual listing allows it to attract a diverse array of investors and expand its influence even further.
Recent Developments
This company is no stranger to innovation and growth. In recent months, Novo Nordisk has advanced its research and development in various therapeutic areas, which marks a committed effort to not only enhance its existing product lines but also to pioneer new treatments. This commitment reflects an overarching goal to transform the healthcare landscape through science.
Contact Information
For further inquiries relating to the Annual General Meeting, the following contacts are available:
Media
Ambre James-Brown
Phone: +45 3079 9289
Email: abmo@novonordisk.com
Liz Skrbkova (US)
Phone: +1 609 917 0632
Email: lzsk@novonordisk.com
Investors
Jacob Martin Wiborg Rode
Phone: +45 3075 5956
Email: jrde@novonordisk.com
Ida Schaap Melvold
Phone: +45 3077 5649
Email: idmg@novonordisk.com
Sina Meyer
Phone: +45 3079 6656
Email: azey@novonordisk.com
Max Ung
Phone: +45 3077 6414
Email: mxun@novonordisk.com
Frequently Asked Questions
What is the date of the Annual General Meeting?
The Annual General Meeting is scheduled for March 27, 2024.
How can shareholders participate in the meeting?
Shareholders can participate in person at Bella Center or virtually via an IT application.
Will the meeting be available for online viewing?
Yes, there will be a live webcast available on Novo Nordisk’s website.
Who is up for re-election on the Board of Directors?
All Board members, including Helge Lund and Henrik Poulsen, are up for re-election.
What are Novo Nordisk's main market listings?
Novo Nordisk's B shares are listed on Nasdaq Copenhagen, and its ADRs are on the New York Stock Exchange under the ticker NVO.
About The Author
Contact Hannah Lewis privately here. Or send an email with ATTN: Hannah Lewis as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.
